Screener
Spero Therapeutics, Inc. SPRO Q4 2025 Annual earnings
Reported March 26, 2026 · After market close
Revenue$41.3MBeat by $15.3M
EPS$0.53Beat by $0.73
Revenue estimate$26.0M
EPS estimate-$0.20
Next report
Nov 12, 2026 (in 2 months)EPS estimate-$0.14
Versus estimates
Revenue
Q1 2026$258.0KIn line
Q4 2025$41.3MBeat by $15.3M
Q3 2025$3.0MMiss by $9.0MQ2 2025$11.8MBeat by $802.0KQ1 2025$5.9MMiss by $5.1MDiluted EPS
FAQ
- When did Spero Therapeutics, Inc. report Q4 2025 earnings?
- Spero Therapeutics, Inc. (SPRO) reported Q4 2025 earnings on March 26, 2026 after market close.
- What were Spero Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Spero Therapeutics, Inc. reported revenue of $41.3M and eps of $0.53 for Q4 2025.
- Did Spero Therapeutics, Inc. beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $26.0M by $15.3M. EPS beat the consensus estimate of $-0.20 by $0.73.
- How did Spero Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 341.4% from $9.4M a year earlier.
- Where can I find Spero Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-126244) and the 10-K periodic report (0001193125-26-126192) directly on SEC EDGAR. The filing index links above go to sec.gov.
